home / stock / trda / trda quote
Last: | $14.34 |
---|---|
Change Percent: | 0.21% |
Open: | $14.33 |
Close: | $14.34 |
High: | $14.46 |
Low: | $14.02 |
Volume: | 38,904 |
Last Trade Date Time: | 05/10/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$14.34 | $14.33 | $14.34 | $14.46 | $14.02 | 38,904 | 05-10-2024 |
$14.36 | $14.02 | $14.36 | $14.44 | $13.8171 | 60,495 | 05-09-2024 |
$14.05 | $13.52 | $14.05 | $14.245 | $13.49 | 57,449 | 05-08-2024 |
$13.88 | $13.79 | $13.88 | $14.11 | $13.355 | 44,564 | 05-07-2024 |
$13.5 | $13.42 | $13.5 | $13.825 | $13.2575 | 25,801 | 05-06-2024 |
$13.16 | $13.7 | $13.16 | $13.8419 | $12.92 | 38,162 | 05-03-2024 |
$13.56 | $13.25 | $13.56 | $13.59 | $12.72 | 67,224 | 05-02-2024 |
$13.25 | $11.98 | $13.25 | $13.36 | $11.98 | 99,256 | 05-01-2024 |
$11.85 | $12.29 | $11.85 | $12.39 | $11.82 | 68,824 | 04-30-2024 |
$12.34 | $12.33 | $12.34 | $12.5536 | $12.06 | 52,697 | 04-29-2024 |
$12.45 | $12.1 | $12.45 | $12.73 | $12.1 | 25,818 | 04-26-2024 |
$12.36 | $12.23 | $12.36 | $12.58 | $11.91 | 84,124 | 04-25-2024 |
$12.43 | $12.79 | $12.43 | $12.79 | $12.31 | 38,559 | 04-24-2024 |
$12.89 | $13.08 | $12.89 | $14.03 | $12.78 | 43,413 | 04-23-2024 |
$13.1 | $12.24 | $13.1 | $13.13 | $12.2 | 119,085 | 04-22-2024 |
$12.15 | $11.83 | $12.15 | $12.19 | $11.8125 | 87,455 | 04-19-2024 |
$11.91 | $12.12 | $11.91 | $12.4 | $11.82 | 130,286 | 04-18-2024 |
$12.22 | $12.71 | $12.22 | $12.89 | $12.16 | 56,429 | 04-17-2024 |
$12.72 | $12.87 | $12.72 | $13.005 | $12.52 | 49,596 | 04-16-2024 |
$12.89 | $13.03 | $12.89 | $13.543 | $12.69 | 108,935 | 04-15-2024 |
News, Short Squeeze, Breakout and More Instantly...
Entrada Therapeutics Inc. Company Name:
TRDA Stock Symbol:
NASDAQ Market:
– Initiated dosing of the fourth and final cohort of Phase 1 clinical trial of ENTR-601-44 for the potential treatment of DMD with data readout on track for October of 2024 – – Achieved $75 million milestone payment from Vertex for the clinical advancement o...
2024-04-25 02:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...